Berobenatide
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Pfizer · Phase 3 · Recruiting · Enrollment 300
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Berobenatide Medium Maintenance Dose | n/r | n/r | n/r | n/r | n/r |
| Placebo Matched to Low-Dose Berobenatide | n/r | n/r | n/r | n/r | n/r |
| Berobenatide Low Maintenance Dose | n/r | n/r | n/r | n/r | n/r |
| Berobenatide High Maintenance Dose | n/r | n/r | n/r | n/r | n/r |
| Placebo Matched to Medium-Dose Berobenatide | n/r | n/r | n/r | n/r | n/r |
| Placebo Matched to High-Dose Berobenatide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.